Drug name - Boniva

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7192938 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid May, 2023

(6 months from now)

US7718634 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid May, 2023

(6 months from now)

US7410957 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid May, 2023

(6 months from now)

Drugs and Companies using IBANDRONATE SODIUM ingredient

Treatment: Treatment and prevention of osteoporosis in postmenopausal women by once-monthly oral administration of ibandronate sodium monohydrate equivalent to 150mg of ibandronic acid; Treatment and prevention of osteoporosis

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET;ORAL Discontinued
EQ 150MG BASE TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.